Literature DB >> 20663889

Identification of E2F1 as an important transcription factor for the regulation of tapasin expression.

Juergen Bukur1, Felix Herrmann, Diana Handke, Christian Recktenwald, Barbara Seliger.   

Abstract

HER-2/neu overexpression in tumor cells caused abnormalities of MHC class I surface expression due to impaired expression of components of the antigen-processing machinery (APM) including the low molecular weight proteins, the transporter associated with antigen processing (TAP), and the chaperone tapasin, whereas the expression of MHC class I heavy chain as well as β(2)-microglobulin was only marginally affected. This oncogene-mediated deficient APM component expression could be reverted by interferon-γ treatment, suggesting a deregulation rather than structural alterations as underlying molecular mechanisms. To determine the level of regulation, the transcriptional activity of APM components was analyzed in HER-2/neu(-) and HER-2/neu(+) cells. All major APM components were transcriptionally down-regulated in HER-2/neu(+) when compared with HER-2/neu(-) cells, which was accompanied by a reduced binding of RNA polymerase II to the APM promoters. Site-directed mutagenesis of the p300- and E2F-binding sites in the APM promoters did not reconstitute the oncogene-mediated decreased transcription rate with the exception of tapasin, which was restored in HER-2/neu(+) cells to levels of wild type tapasin promoter activity in HER-2/neu(-) fibroblasts. The E2F-directed control of tapasin expression was further confirmed by chromatin immunoprecipitation analyses showing that E2F1 and p300 bind to the tapasin and APM promoters in both cell lines. Moreover, siRNA-mediated silencing of E2F1 was associated with an increased tapasin expression, whereas transient overexpression of E2F1 launch a reduced tapasin transcription, suggesting that E2F1 is an essential transcription factor for tapasin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663889      PMCID: PMC2945534          DOI: 10.1074/jbc.M109.094284

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  89 in total

1.  Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.

Authors:  Y Takahashi; J B Rayman; B D Dynlacht
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

2.  Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.

Authors:  K Delp; F Momburg; C Hilmes; C Huber; B Seliger
Journal:  Bone Marrow Transplant       Date:  2000-05       Impact factor: 5.483

Review 3.  The E2F transcriptional network: old acquaintances with new faces.

Authors:  Desssislava K Dimova; Nicholas J Dyson
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

Review 4.  Accessory molecules in the assembly of major histocompatibility complex class I/peptide complexes: how essential are they for CD8(+) T-cell immune responses?

Authors:  Natalio Garbi; Satoshi Tanaka; Maries van den Broek; Frank Momburg; Günter J Hämmerling
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

5.  Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

Authors:  Angelica Facoetti; Rosanna Nano; Paola Zelini; Patrizia Morbini; Eugenio Benericetti; Mauro Ceroni; Michael Campoli; Soldano Ferrone
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

6.  Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells.

Authors:  Chien-Chung Chang; Takeshi Ogino; David W Mullins; Janine L Oliver; Galina V Yamshchikov; Nobuyuki Bandoh; Craig L Slingluff; Soldano Ferrone
Journal:  J Biol Chem       Date:  2006-04-28       Impact factor: 5.157

7.  Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival.

Authors:  Yuanmei Lou; Timothy Z Vitalis; Genc Basha; Bing Cai; Susan S Chen; Kyung Bok Choi; Andrew P Jeffries; W Mark Elliott; Derek Atkins; Barbara Seliger; Wilfred A Jefferies
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

Review 8.  Antigen-processing machinery breakdown and tumor growth.

Authors:  B Seliger; M J Maeurer; S Ferrone
Journal:  Immunol Today       Date:  2000-09

9.  Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications.

Authors:  Lizzia Raffaghello; Ignazia Prigione; Paola Bocca; Fabio Morandi; Marta Camoriano; Claudio Gambini; Xinhui Wang; Soldano Ferrone; Vito Pistoia
Journal:  Oncogene       Date:  2005-07-07       Impact factor: 9.867

Review 10.  Challenges and prospects of immunotherapy as cancer treatment.

Authors:  Maria Rescigno; Francesca Avogadri; Giuseppe Curigliano
Journal:  Biochim Biophys Acta       Date:  2007-07-17
View more
  16 in total

1.  Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma.

Authors:  Simon Jasinski-Bergner; Christine Stoehr; Juergen Bukur; Chiara Massa; Juliane Braun; Stefan Hüttelmaier; Verena Spath; Roland Wartenberg; Wolfgang Legal; Helge Taubert; Sven Wach; Bernd Wullich; Arndt Hartmann; Barbara Seliger
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

2.  Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.

Authors:  Paolo A Ascierto; Antonio M Grimaldi; Ana Carrizosa Anderson; Carlo Bifulco; Alistair Cochran; Claus Garbe; Alexander M Eggermont; Mark Faries; Soldano Ferrone; Jeffrey E Gershenwald; Thomas F Gajewski; Ruth Halaban; F Stephen Hodi; Richard Kefford; John M Kirkwood; James Larkin; Sancy Leachman; Michele Maio; Richard Marais; Giuseppe Masucci; Ignacio Melero; Giuseppe Palmieri; Igor Puzanov; Antoni Ribas; Yvonne Saenger; Bastian Schilling; Barbara Seliger; David Stroncek; Ryan Sullivan; Alessandro Testori; Ena Wang; Gennaro Ciliberto; Nicola Mozzillo; Francesco M Marincola; Magdalena Thurin
Journal:  J Transl Med       Date:  2014-10-28       Impact factor: 5.531

3.  Stimulation of dendritic cells with Helicobacter pylori vacuolating cytotoxin negatively regulates their maturation via the restoration of E2F1.

Authors:  J M Kim; J S Kim; D Y Yoo; S H Ko; N Kim; H Kim; Y-J Kim
Journal:  Clin Exp Immunol       Date:  2011-10       Impact factor: 4.330

4.  E2F1: a potential therapeutic target for systematic lupus erythematosus.

Authors:  Xin-Yu Fang; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2013-09-27       Impact factor: 2.631

5.  Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid.

Authors:  Claudia Lennicke; Jette Rahn; Jürgen Bukur; Falko Hochgräfe; Ludger A Wessjohann; Rudolf Lichtenfels; Barbara Seliger
Journal:  Oncoimmunology       Date:  2016-12-21       Impact factor: 8.110

Review 6.  Oncogenic growth factor signaling mediating tumor escape from cellular immunity.

Authors:  Fernando Concha-Benavente; Robert L Ferris
Journal:  Curr Opin Immunol       Date:  2017-02-14       Impact factor: 7.486

Review 7.  HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy.

Authors:  Luke Maggs; Ananthan Sadagopan; Ali Sanjari Moghaddam; Soldano Ferrone
Journal:  Trends Cancer       Date:  2021-09-03

8.  Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells.

Authors:  Karthikeyan Subbarayan; Sandra Leisz; Claudia Wickenhauser; Daniel Bethmann; Chiara Massa; André Steven; Barbara Seliger
Journal:  Oncoimmunology       Date:  2018-01-16       Impact factor: 8.110

9.  Impact of beta 2-microglobulin on tapasin expression and covalent association.

Authors:  Laura C Simone; Brittney L Smith; Joyce C Solheim
Journal:  Cell Immunol       Date:  2012-10-01       Impact factor: 4.868

10.  Identification of 14-3-3β gene as a novel miR-152 target using a proteome-based approach.

Authors:  Simon Jasinski-Bergner; Franziska Stehle; Evamaria Gonschorek; Jana Kalich; Kristin Schulz; Stefan Huettelmaier; Juliane Braun; Barbara Seliger
Journal:  J Biol Chem       Date:  2014-09-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.